EHD3 and lung adenocarcinoma: From the TCGA dataset, only small portions of breast cancers (1.1%, 1/87), lung adenocarcinomas (6.9%, 2/29), and squamous cell lung cancers (0.0%, 0/40) had EHD3 hypermethylation (Figure S1).